NCT00314509 Safety and Tolerability of Ciclesonide and Formoterol Fumarate Inhaled Once Daily in Patients With Asthma (18 to 75 y) (BY9010/M1-506) Status COMPLETED Phase PHASE2
NCT00311051 Ramatroban/Montelukast Versus Montelukast/Placebo on the Early Allergic Reaction in Asthma Sensitive to House Dust Mite Status WITHDRAWN Phase PHASE2/PHASE3
NCT00308685 Chronic-Dose Safety and Efficacy Study of Albuterol-HFA-BAI in Pediatric Asthmatics Status COMPLETED Phase PHASE3
NCT00306163 Responsiveness of Lower Airways in Adult Patients (18-60 Years) With Stable Asthma After Treatment With Ciclesonide and Fluticasone Propionate (BY9010/NL-101) Status COMPLETED Phase PHASE3
NCT00305461 Effect of Ciclesonide on Quality of Life in Patients With Moderate Persistent Asthma (21 to 65 y) (BY9010/AR-101) Status COMPLETED Phase PHASE3
NCT00299065 Safety Study of Zileuton Injection in Patients With Asthma Status COMPLETED Phase PHASE1/PHASE2
NCT00298337 Use of Probiotic Bacteria in Prevention of Allergic Disease in Children 1999-2008 Status UNKNOWN Phase PHASE2/PHASE3
NCT00296491 Study Of Allergic Rhinitis In Patients Who Also Have Asthma Status COMPLETED Phase PHASE4
NCT00294398 Inhaled Corticosteroids After a Pediatric Emergency Visit for Asthma Status COMPLETED Phase NA
NCT00292877 The Prednisone-sparing Effect of Anti-IL-5 Antibody (SB-240563) Status COMPLETED Phase PHASE2
NCT00291382 Airway Hyper-responsiveness Study In Asthma Using Salmeterol/Fluticasone Propionate Combination Product Status COMPLETED Phase PHASE4
NCT00290264 SALTO - Symbicort Single Inhaler Therapy Use in Adolescent Adults and Adults With Persistent Asthma Status COMPLETED Phase PHASE3
NCT00289874 Montelukast in Pediatric Allergic Asthma (0476-336)(COMPLETED) Status COMPLETED Phase PHASE3